BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36422560)

  • 1. Osmotic Pump Drug Delivery Systems-A Comprehensive Review.
    Almoshari Y
    Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmotic pumps in drug delivery.
    Verma RK; Arora S; Garg S
    Crit Rev Ther Drug Carrier Syst; 2004; 21(6):477-520. PubMed ID: 15658934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of recent patents on oral osmotic drug delivery systems.
    Kumar P; Mishra B
    Recent Pat Drug Deliv Formul; 2007; 1(3):236-55. PubMed ID: 19075891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic drug delivery system as a part of modified release dosage form.
    Keraliya RA; Patel C; Patel P; Keraliya V; Soni TG; Patel RC; Patel MM
    ISRN Pharm; 2012; 2012():528079. PubMed ID: 22852100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology.
    Chen J; Pan H; Ye T; Liu D; Li Q; Chen F; Yang X; Pan W
    Curr Drug Metab; 2016; 17(3):279-91. PubMed ID: 26467064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
    Patel KN; Mehta TA
    PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmotic micropumps for drug delivery.
    Herrlich S; Spieth S; Messner S; Zengerle R
    Adv Drug Deliv Rev; 2012 Nov; 64(14):1617-27. PubMed ID: 22370615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.
    McLane VD; Bergquist I; Cormier J; Barlow DJ; Houseknecht KL; Bilsky EJ; Cao L
    Life Sci; 2017 Sep; 185():1-7. PubMed ID: 28723417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release Mechanism Between Ion Osmotic Pressure and Drug Release in Ionic-Driven Osmotic Pump Tablets (I).
    Cheng L; Gao S; Ouyang D; Wang H; Wang Y; Pan W; Yang X
    AAPS PharmSciTech; 2018 Feb; 19(2):803-811. PubMed ID: 29019066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
    Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
    Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system.
    Wang C; Chen F; Li JZ; Tang H; Li X; Yan KS; Ye GH; Pan WS
    Yakugaku Zasshi; 2008 May; 128(5):773-82. PubMed ID: 18451626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The delivery mechanism of micro-porous osmotic pump tablets].
    Zhao XL; Li Q; Gong XF; Li SM
    Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
    Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
    J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insight to osmotic drug delivery.
    Sareen R; Jain N; Kumar D
    Curr Drug Deliv; 2012 May; 9(3):285-96. PubMed ID: 22452403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in asymmetric membrane capsule based osmotic pump: a patent overview.
    Patel A; Mehta T; Patel J; Patel M; Patel K; Patel N
    Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):66-72. PubMed ID: 22191697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation aspects in the development of osmotically controlled oral drug delivery systems.
    Verma RK; Krishna DM; Garg S
    J Control Release; 2002 Feb; 79(1-3):7-27. PubMed ID: 11853915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmotic-controlled release oral tablets: technology and functional insights.
    Ogueri KS; Shamblin SL
    Trends Biotechnol; 2022 May; 40(5):606-619. PubMed ID: 34689998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation.
    Gong W; Ma R; Mei D; Jing P; Dong X; Li B; Yang Y; Du L; Mei XG; Hu FQ
    Drug Deliv; 2014 Feb; 21(1):1-7. PubMed ID: 24102136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three dimensional structural insight of laser drilled orifices in osmotic pump tablets.
    Wu L; Wang L; Wang S; Xiao T; Chen M; Shao Q; York P; Singh V; Yin X; Gu J; Zhang J
    Eur J Pharm Sci; 2016 Oct; 93():287-94. PubMed ID: 27562708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Applicability of a natural swelling matrix as the propellant of osmotic pump tablets].
    Wu L; Li HY; Yin XZ; Li Y; Chen JX; Hu RF; Zhang JW
    Yao Xue Xue Bao; 2013 Aug; 48(8):1319-24. PubMed ID: 24187843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.